TAK-128
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAK-128, covering 2012-02-28 to 2012-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy [Phase 2]